Advertisement
Advertisement

NDRA

NDRA logo

ENDRA Life Sciences Inc. Common Stock

4.45
USD
Sponsored
+0.18
+4.10%
Jun 09, 13:12 UTC -4
Open

NDRA Earnings Reports

Positive Surprise Ratio

NDRA beat 18 of 29 last estimates.

62%

Next Report

Date of Next Report
Aug 12, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$1.16
Implied change from Q1 26 (Revenue/ EPS)
--
/
-35.56%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-32.16%

ENDRA Life Sciences Inc. Common Stock earnings per share and revenue

On May 15, 2026, NDRA reported earnings of -1.80 USD per share (EPS) for Q1 26, missing the estimate of -1.25 USD, resulting in a -43.47% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.13% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -1.16 USD, with revenue projected to reach -- USD, implying an decrease of -35.56% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Autonomix Medical, Inc. Common Stock
Report Date
May 27, 2026 For Q4 26
Estimate
-$0.26
Actual
-$0.23
Surprise
+13.27%
logo
Mesa Laboratories Inc
Report Date
May 27, 2026 For Q4 26
Estimate
$0.34
Actual
-$0.75
Surprise
-316.26%
FAQ
For Q1 2026, ENDRA Life Sciences Inc. Common Stock reported EPS of -$1.80, missing estimates by -43.47%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.13%, changed from $5.05 before the earnings release to $5.41 the day after.
The next earning report is scheduled for Aug 12, 2026.
Based on 3 analysts, ENDRA Life Sciences Inc. Common Stock is expected to report EPS of -$1.16 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement